# Fresenius Kabi breaks ground on $250M manufacturing campus in Melrose Park

Fresenius Kabi broke ground on a $250 million expansion of its manufacturing campus in Melrose Park, Illinois. The project will create multiple new buildings with automated aseptic filling lines and is expected to be completed in 2026, creating hundreds of jobs.

- Type: Expansion
- Announced: 2017-09-21
- Where: Melrose Park, Illinois, United States
- Value: $250.0M
- Starts operating: 2026
- Status: under construction
- Products: generic sterile injectable pharmaceuticals
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Fresenius Kabi](https://endata.com/companies/9091.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/250-million-plant-breaks-ground-in-melrose-park-300523583.html), 2017-09-21: "Fresenius Kabi will invest the $250 million in the project over the next decade."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.